Neuropathic pain is a major area of unmet medical need. It can be caused by trauma to the peripheral or central nervous system, by chemotherapeutics or other drug treatments, or by metabolic disease. The therapeutics currently used to treat neuropathic pain are not sufficiently effective and have poor side-effect profiles.
Dedicated to delivering innovative medicines for patients with neuropathic pain.
4E is targeting the underlying mechanisms causing pain in neuropathic pain patients. We are developing therapeutics that can transform the lives of people suffering from neuropathic pain.
Leading the charge to a pain free tomorrow.
4E Therapeutics is a neuroscience company based in Austin, Texas focused on developing next generation treatments for pain. The company, founded by a world-class team of experts, is dedicated to improving the lives of those living in pain by developing innovative, non-addictive pain medications that target the underlying neurological mechanisms that cause pain. With a history of commercial success and scientific expertise, 4E Therapeutics has entered clinical development for a cutting edge therapy for chronic neuropathic pain and is also at the forefront of discovering and developing compounds to treat migraine and acute pain.
Leadership Team
Press
4E Therapeutics Awarded NIH Research Grant to Develop Non-Opioid Treatment for Pain to End Addiction
AUSTIN, TX – Nov. 10, 2021 /PRNewswire/ -- 4E Therapeutics, Inc., a neuroscience company based in Austin, Texas developing a first-in-class treatment for neuropathic pain, announced that it has been awarded a…
Read More
